Literature DB >> 25081209

Chimeric bifunctional oligonucleotides as a novel tool to invade telomerase assembly.

Dulat Azhibek1, Maria Zvereva2, Timofei Zatsepin1, Maria Rubtsova3, Olga Dontsova3.   

Abstract

Telomerase is a key participant in the telomere length maintaining system in eukaryotic cells. Telomerase RNA and protein reverse transcriptase subunits are essential for the appearance of active telomerase in vitro. Telomerase is active in many cancer types and is a potential target for anticancer drug development. Here we report a new approach for impairing telomerase function at the stage of human telomerase assembly. The approach is based on the application of chimeric bifunctional oligonucleotides that contain two oligonucleotide parts complementary to the functional domains of telomerase RNA connected with non-nucleotide linkers in different orientations (5'-3', 5'-5' or 3'-3'). Such chimeras inhibited telomerase in vitro in the nM range, but were effective in vivo in sub-nM concentrations, predominantly due to their effect on telomerase assembly and dimerization.
© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25081209      PMCID: PMC4150790          DOI: 10.1093/nar/gku688

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  34 in total

1.  Human telomerase contains two cooperating telomerase RNA molecules.

Authors:  C Wenz; B Enenkel; M Amacker; C Kelleher; K Damm; J Lingner
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Polyribosome analysis on sucrose gradients produced by the freeze-thaw method.

Authors:  P Fourcroy; S Cuiller; F C Largitte; C Lambert
Journal:  J Biochem Biophys Methods       Date:  1981-03

3.  Vaults and telomerase share a common subunit, TEP1.

Authors:  V A Kickhoefer; A G Stephen; L Harrington; M O Robinson; L H Rome
Journal:  J Biol Chem       Date:  1999-11-12       Impact factor: 5.157

4.  Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.

Authors:  Brittney-Shea Herbert; Krisztina Pongracz; Jerry W Shay; Sergei M Gryaznov; Brittney Shea-Herbert
Journal:  Oncogene       Date:  2002-01-21       Impact factor: 9.867

5.  Reverse transcriptase motifs in the catalytic subunit of telomerase.

Authors:  J Lingner; T R Hughes; A Shevchenko; M Mann; V Lundblad; T R Cech
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

6.  Structure of the human telomerase RNA pseudoknot reveals conserved tertiary interactions essential for function.

Authors:  Carla A Theimer; Craig A Blois; Juli Feigon
Journal:  Mol Cell       Date:  2005-03-04       Impact factor: 17.970

7.  Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells.

Authors:  Raffaella Villa; Marco Folini; Chiara Della Porta; Alessandra Valentini; Marzia Pennati; Maria Grazia Daidone; Nadia Zaffaroni
Journal:  Carcinogenesis       Date:  2003-05       Impact factor: 4.944

8.  Structure and function of the smallest vertebrate telomerase RNA from teleost fish.

Authors:  Mingyi Xie; Axel Mosig; Xiaodong Qi; Yang Li; Peter F Stadler; Julian J-L Chen
Journal:  J Biol Chem       Date:  2007-11-26       Impact factor: 5.157

9.  Dynamics of human telomerase RNA structure revealed by antisense oligonucleotide technique.

Authors:  Daria V Vasilkova; Dulat M Azhibek; Timofei S Zatsepin; Yulia V Naraikina; Vladimir S Prassolov; Maria M Prokofjeva; Maria I Zvereva; Maria P Rubtsova
Journal:  Biochimie       Date:  2013-09-10       Impact factor: 4.079

10.  Structure of active dimeric human telomerase.

Authors:  Anselm Sauerwald; Sara Sandin; Gaël Cristofari; Sjors H W Scheres; Joachim Lingner; Daniela Rhodes
Journal:  Nat Struct Mol Biol       Date:  2013-03-10       Impact factor: 15.369

View more
  4 in total

1.  A study on endonuclease BspD6I and its stimulus-responsive switching by modified oligonucleotides.

Authors:  Liudmila A Abrosimova; Anzhela Yu Migur; Elena A Kubareva; Timofei S Zatsepin; Aleksandra V Gavshina; Alfiya K Yunusova; Tatiana A Perevyazova; Alfred Pingoud; Tatiana S Oretskaya
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

2.  Comprehensive analysis of telomerase inhibition by gallotannin.

Authors:  Nikita Savelyev; Polina Baykuzina; Svetlana Dokudovskaya; Olga Lavrik; Maria Rubtsova; Olga Dontsova
Journal:  Oncotarget       Date:  2018-04-10

3.  Protein encoded in human telomerase RNA is involved in cell protective pathways.

Authors:  Maria Rubtsova; Yulia Naraykina; Daria Vasilkova; Mark Meerson; Maria Zvereva; Vladimir Prassolov; Vasily Lazarev; Valentin Manuvera; Sergey Kovalchuk; Nickolay Anikanov; Ivan Butenko; Olga Pobeguts; Vadim Govorun; Olga Dontsova
Journal:  Nucleic Acids Res       Date:  2018-09-28       Impact factor: 16.971

4.  PARP1 Regulates the Biogenesis and Activity of Telomerase Complex Through Modification of H/ACA-Proteins.

Authors:  Nikita V Savelyev; Nikita M Shepelev; Olga I Lavrik; Maria P Rubtsova; Olga A Dontsova
Journal:  Front Cell Dev Biol       Date:  2021-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.